Carolina C. De Araujo
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
T cell-associated immunity induced by heterologous recombinant BCG and purified protein vaccination confers cross-variant protection against SARS-CoV-2.
Journal: Human vaccines & immunotherapeutics
Published: July 09, 2026
Pathogenicity and virulence of Brucella: Strategies for metabolic adaptation and immune evasion.
Journal: Virulence
Published: November 10, 2025
An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants.
Journal: Pathogens (Basel, Switzerland)
Published: October 04, 2024
Guanylate-binding protein-5 is involved in inflammasome activation by bacterial DNA but only the cooperation of multiple GBPs accounts for control of Brucella abortus infection.
Journal: Frontiers in immunology
Published: November 20, 2023
Current Understanding of Bacillus Calmette-Guérin-Mediated Trained Immunity and Its Perspectives for Controlling Intracellular Infections.
Journal: Pathogens (Basel, Switzerland)
Published: November 01, 2023
Bacillus Calmette-Guérin-Trained Macrophages Elicit a Protective Inflammatory Response against the Pathogenic Bacteria Brucella abortus.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 29, 2022
Guanylate binding proteins contained in the murine chromosome 3 are important to control mycobacterial infection.
Journal: Journal of leukocyte biology
Published: January 08, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026